Selective adhesion-molecule therapy and inflammatory bowel disease [10]

New England Journal of Medicine

Volumn 354, Issue 6, 2006, Pages 644-

  Chaudhuri, Abhijit ^a  

^a Essex Centre for Neurological Sciences   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTEGRIN; ALPHA INTEGRIN ANTIBODY; ANTIBODY; NATALIZUMAB; UNCLASSIFIED DRUG;

CROHN DISEASE; DEMYELINATING DISEASE; DIFFERENTIAL DIAGNOSIS; DISEASE EXACERBATION; DRUG EFFICACY; DRUG SAFETY; ENTERITIS; HUMAN; LETTER; MULTIPLE SCLEROSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY;

ANTIBODIES, MONOCLONAL; CELL ADHESION MOLECULES; CROHN DISEASE; DIAGNOSIS, DIFFERENTIAL; HUMANS; INTEGRIN ALPHA CHAINS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS;

EID: 32144433671     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc053338     Document Type: Letter

References (6)

1. Podolsky DK. Selective adhesion-molecule therapy and inflammatory bowel disease - a tale of Janus? N Engl J Med 2005;353:1965-8.
2. Bjursten M, Bland PW, Willen R, Hornquist EH. Long-term treatment with alpha-4 integrin antibodies aggravates colitis in G-alphai2-deficient mice. Eur J Immunol 2005;35:2274-83.
3. Minuk GY, Lewkonia RM. Possible familial association of multiple sclerosis and inflammatory bowel disease. N Engl J Med 1986;314:586.
4. Gupta G, Gelfand JM, Lewis JD. Increased risk of demyelinating diseases in patients with inflammatory bowel disease. Gastroenterology 2005;129:819-26.
5. Constantinescu CS, Whiteley A, Blumhardt LD. Long term azathioprine fails to prevent onset of multiple sclerosis: report of two cases. Mult Scler 2000;6:362-3.
6. Chaudhuri A. Natalizumab for multiple sclerosis: lessons in clinical trial. BMJ (in press).